Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03189836
Title Study of ACTR707 in Combination With Rituximab in Subjects With Relapsed or Refractory B Cell Lymphoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Unum Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center Gilbert Arizona 85234 United States Details
Yale University New Haven Connecticut 06520 United States Details
Emory University, Winship Cancer Institute Atlanta Georgia 30322 United States Details
Loyola University Maywood Illinois 60153 United States Details
Indiana Bone and Marrow Transplantation Indianapolis Indiana 46327 United States Details
University of Maryland Baltimore Maryland 21201 United States Details
University of Minnesota Minneapolis Minnesota 55455 United States Details
Ohio State University Columbus Ohio 43210 United States Details
Tennessee Oncology - Nashville Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field